Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sait Kitapli

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Helicobacter|July 7, 2026
Active Helicobacter pylori Infection and Survival Outcomes in De Novo Metastatic Colorectal Cancer: A Retrospective Cohort StudySait Kitapli, Ali Alkan, Ozgur Tanriverdi
European Journal of Cancer (Oxford, England : 1990)|January 4, 2025
Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockersSait Kitapli, Ali Alkan, Ozgur Tanriverdi
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2025
Exploring the prognostic value of the magnesium-immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving NivolumabSait Kitapli, Melih Akpunar, Ali Alkan, et al.
Endocrine|February 2, 2026
Knowledge, perceptions and attitudes toward diabetes care in oncology: a pilot survey across specialties (DiaLog Study)Guler Nur Tekustun, Besra Hazal Yesil-Gurel, Sait Kitapli, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 3, 2025
Medical oncologists' dance with international guidelines and national reimbursement: insights from a survey in TürkiyeOzgur Tanriverdi, Melek Ozdemir, Emre Hafizoglu, et al.
Oncology Research and Treatment|January 13, 2026
Proliferation-Guided Risk Stratification in HER2-Low vs. HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective AnalysisSait Kitapli, Özgür Tanriverdi, İsmail Bayrakci, et al.
Scientific Reports|May 9, 2024
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatmentMurat Bardakci, Hilal Karakas, Dogan Bayram, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Helicobacter|July 7, 2026
Active Helicobacter pylori Infection and Survival Outcomes in De Novo Metastatic Colorectal Cancer: A Retrospective Cohort StudySait Kitapli, Ali Alkan, Ozgur Tanriverdi
European Journal of Cancer (Oxford, England : 1990)|January 4, 2025
Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockersSait Kitapli, Ali Alkan, Ozgur Tanriverdi
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2025
Exploring the prognostic value of the magnesium-immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving NivolumabSait Kitapli, Melih Akpunar, Ali Alkan, et al.
Endocrine|February 2, 2026
Knowledge, perceptions and attitudes toward diabetes care in oncology: a pilot survey across specialties (DiaLog Study)Guler Nur Tekustun, Besra Hazal Yesil-Gurel, Sait Kitapli, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 3, 2025
Medical oncologists' dance with international guidelines and national reimbursement: insights from a survey in TürkiyeOzgur Tanriverdi, Melek Ozdemir, Emre Hafizoglu, et al.
Oncology Research and Treatment|January 13, 2026
Proliferation-Guided Risk Stratification in HER2-Low vs. HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective AnalysisSait Kitapli, Özgür Tanriverdi, İsmail Bayrakci, et al.
Scientific Reports|May 9, 2024
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatmentMurat Bardakci, Hilal Karakas, Dogan Bayram, et al.
Pageof 1